KR840002824A - Method for producing N-oxide compound - Google Patents

Method for producing N-oxide compound

Info

Publication number
KR840002824A
KR840002824A KR1019820005887A KR820005887A KR840002824A KR 840002824 A KR840002824 A KR 840002824A KR 1019820005887 A KR1019820005887 A KR 1019820005887A KR 820005887 A KR820005887 A KR 820005887A KR 840002824 A KR840002824 A KR 840002824A
Authority
KR
South Korea
Prior art keywords
group
ethyl ester
acid ethyl
pyridyl
formula
Prior art date
Application number
KR1019820005887A
Other languages
Korean (ko)
Inventor
짐머만 마르쿠스 (외 1)
Original Assignee
아놀드 세일러, 에른스트 알테르
시바-가이기 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아놀드 세일러, 에른스트 알테르, 시바-가이기 에이지 filed Critical 아놀드 세일러, 에른스트 알테르
Publication of KR840002824A publication Critical patent/KR840002824A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음No content

Description

N-옥사이드 화합물의 제조방법Method for producing N-oxide compound

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (12)

a) 일반식(Ⅱ)의 화합물 또는 이의 토오토머 또는 상응하는 토오토머 혼합물을 폐환시키거나, 또는 b) 일반식 Py-CHO(Ⅲ)의 화합물 또는 이의 반응성 및 작용성 유도체를 일반식(Ⅳ)의 화합물과 또는 이의 토오토머 또는 상응하는 토오토머 혼합물과 반응시키거나, 또는a) terminating the compound of formula (II) or a tautomer or corresponding tautomer mixture thereof, or b) a compound of formula P y -CHO (III) or a reactive and functional derivative thereof Reacting with a compound of (IV) or with a tautomer or corresponding tautomer mixture thereof, or c) 일반식(Ⅴ)화합물에 있어서, Ac1°및/또는 Ac2°기를 Ac1및/또는 Ac2기를 전환시키거나, 또는c) in the compound of formula (V), converts Ac 1 ° and / or Ac 2 ° groups to Ac 1 and / or Ac 2 groups, or d) 일반식(Ⅵ)화합물에 있어서, Py0기를 산화하여 상응하는 N-옥시도피리돌기를 형성하며:d) For compounds of formula (VI), the Py 0 group is oxidized to form the corresponding N-oxidopyridol group: R2또는 R3가 하이드록시-저급알킬일 경우, 인접한 아실기 Ac1또는 Ac2와 함께 2-옥시-1-옥소-저급알킬렌기를 형성하며, 카보닐기는 1,4-디하이드로피리딘환의 3-또는 5-원 탄소 원자에 결합되는 일반식(Ⅰ)의 화합물은 R2또는 R3가 유리 또는 에스테르화 하이드록시 함유 저급알킬을 나타내는 일반식(Ⅱ), (Ⅳ), (Ⅴ) 및 (Ⅵ)의 출발물질 및 일반식(Ⅴ)의 Ac1또는 Ac2또는 Ac1°또는 Ac2°가 에스테르화 카복실기를 나타내는 출발물질로서 a) 내지 b)의 공정중 하나의 반응조건하에 직접 형성될 수 있으며, 상기 일반식(Ⅱ) 내지 (Ⅵ)의 출발물질에 있어서, 이들 물질이 염-형성기를 갖는 한, 이들의 염의 형태로 사용할 수 있으며(여기에서 Py, P1, R2, R3, Ac1및 Ac2는 하기에서 정의되는 바와 같다), 필요시, 생성된 일반식(Ⅰ)의 화합물을 일반식(Ⅰ)의 다른 화합물로 전환시키고, 및/또는, 필요시, 생성된 염을 유리화합물 또는 다른 염으로 전환시키고, 및/또는, 필요시, 염-형성기를 갖는 생성된 일반식(Ⅰ)의 유리화합물은 염으로 전환시키고, 및/또는, 필요시, 생성된 이성체의 혼합물을 각 이성체로 분리시킴을 특징으로 하는 일반식(Ⅰ)의 N-옥사이드 화합물 및 염-형성기를 갖는 일반식(Ⅰ) 화합물의 염을 제조하는 방법.When R 2 or R 3 is hydroxy-lower alkyl, it forms a 2-oxy-1-oxo-lower alkylene group together with the adjacent acyl group Ac 1 or Ac 2, and the carbonyl group is a 1,4-dihydropyridine ring. Compounds of formula (I) bonded to 3- or 5-membered carbon atoms include those of formulas (II), (IV), (V), wherein R 2 or R 3 represents a free or esterified hydroxy containing lower alkyl; The starting material of (VI) and Ac 1 or Ac 2 or Ac 1 ° or Ac 2 ° of the general formula (V) are starting materials representing esterified carboxyl groups and are formed directly under the reaction conditions of one of the processes of a) to b). In the starting materials of the general formulas (II) to (VI), as long as these materials have salt-forming groups, they may be used in the form of their salts (here, P y , P 1 , R 2 , R 3, are as defined in to the Ac 1 and Ac 2), a compound represented by the general formula (ⅰ) with, if necessary, create the by the general formula (ⅰ) The free compound of formula (I), which is converted into a compound and / or if necessary, converts the resulting salt into a free compound or another salt, and / or, if necessary, has a salt-forming group, Salts of compounds of formula (I) having N-oxide compounds of formula (I) and salt-forming groups, characterized in that they are converted and / or if necessary, a mixture of the resulting isomers is separated into individual isomers. How to manufacture. 상기일반식에서,In the above formula, Py는 비치환 또는 치환된 N-옥시도피리딜기를 나타내고,P y represents an unsubstituted or substituted N-oxidopyridyl group, R1은 수소 또는 비치환 또는 치환된 저급알킬을 나타내고,R 1 represents hydrogen or unsubstituted or substituted lower alkyl, R2및 R3의 하나는 저급 알킬을 나타내고 다른 하나는 수소; 저급알킬;유리, 에테르화 또는 에스테르화 카복시, 옥소, 기능적으로 변형된 카복시 또는 유리 또는 치환된 아미노 또는 이미노를 함유하는 저급알킬; 기능적으로 병형된 카복시; 또는 유리 또는 치환된 아미노를 나타내며(여기서 아미노기 R2또는 R3는 저급 알킬기 R1에 결합되거나 또는 R2또는 R3가 하이드록시-저급 알킬을 나타내는 경우, 이 하이드록시-저급알킬은 인접한 아실기 Ac1또는 Ac2와 함께 2-옥시-1-옥소-저급알킬렌기를 형성하며, 카보닐기는 1,4-디하이드로피리딘 환의 3-또는 5-원 탄소원자에 결합된다.),One of R 2 and R 3 represents lower alkyl and the other is hydrogen; Lower alkyl; lower alkyl containing free, etherified or esterified carboxy, oxo, functionally modified carboxy or free or substituted amino or imino; Functionally diseased carboxy; Or free or substituted amino, wherein amino group R 2 or R 3 is bonded to lower alkyl group R 1 , or when R 2 or R 3 represents hydroxy-lower alkyl, this hydroxy-lower alkyl is an adjacent acyl group Together with Ac 1 or Ac 2 form a 2-oxy-1-oxo-lower alkylene group, the carbonyl group being bonded to the 3- or 5-membered carbon atom of the 1,4-dihydropyridine ring.), Ac1및 Ac2는 각기 산의 아실기를 나타내고,Ac 1 and Ac 2 each represent an acyl group of an acid, X 및 Y기를 하나는 일반식 -NH-R1의 기를 나타내고, 다른 하나는 하이드록시 또는 일반식 NH-R1의 기를 나타내고,One of the X and Y groups represents a group of the general formula —NH—R 1 , the other represents a hydroxy or a group of the general formula NH—R 1 , Ac1°및 Ac2°기의 하나는 Ac1또는 Ac2기로 전환될 수 있는 기를 나타내고, 다른 하나는 Ac1또는 Ac2또는 Ac1또는 Ac2로 전환될 수 있는 기를 나타내고,One of the Ac 1 ° and Ac 2 ° groups represents a group that can be converted to an Ac 1 or Ac 2 group, the other represents a group that can be converted to Ac 1 or Ac 2 or Ac 1 or Ac 2 , Py0는 비치환 또는 치환된 피리딜기를 나타낸다.P y0 represents an unsubstituted or substituted pyridyl group. 제1항에 있어서, 피리딘-3-카복스알데히드-1-옥사이드를 아세토아세트산 에틸 에스테르 및 암모니아와 반응시켜 2,6-디메틸-4-(1-옥시도-3-피리딜)-1,4-디하드로피리딘-3,5-디카복실산 디에틸 에스테르를 수득함을 특징으로 하는 방법.The method of claim 1, wherein pyridine-3-carboxaldehyde-1-oxide is reacted with acetoacetic acid ethyl ester and ammonia to give 2,6-dimethyl-4- (1-oxido-3-pyridyl) -1,4 -Dihydropyridine-3,5-dicarboxylic acid diethyl ester. 제1항에 있어서, 2-메틸피리딘-3-카복스알데히드-1-옥사이드를 아세토아세트산 에틸 에스테르 및 암모니아와 반응시켜 2,6-디메틸-4-(2-메틸-1-옥시도-3-피리딜)-1,4-디하이드로피리딘-3,5-디카복실산 디에틸에스테르를 수득함을 특징으로 하는 방법.The method of claim 1, wherein 2-methylpyridine-3-carboxaldehyde-1-oxide is reacted with acetoacetic acid ethyl ester and ammonia to give 2,6-dimethyl-4- (2-methyl-1-oxido-3- Pyridyl) -1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester. 제1항에 있어서, 2-클로로피리딘-3-카복스알데히드-1-옥사이드를 아세토아세트산 및 암모니아와 반응시켜 2,6-디메틸-4-(2-클로로-1-옥시도-3-피리딜)-1,4-디하이드로피리딘-3,5-디카복실산 디에틸에스테르를 수득함을 특징으로 하는 방법.The method of claim 1, wherein 2-chloropyridine-3-carboxaldehyde-1-oxide is reacted with acetoacetic acid and ammonia to give 2,6-dimethyl-4- (2-chloro-1-oxido-3-pyridyl ) -1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester. 제1항에 있어서, 2-메틸티오피리딘-3-카복스알데히드-1-옥사이드를 아세토아세트산 에틸 에스테르 및 암모니아와 반응시켜 2,6-디메틸-4-(2-메틸티오-1-옥시도-3-피리딜)-1,4-디하이드로피리딘-3,5-디카복실산 디에틸에스테르를 수득함을 특징으로 하는 방법.The method of claim 1, wherein 2-methylthiopyridine-3-carboxaldehyde-1-oxide is reacted with acetoacetic acid ethyl ester and ammonia to give 2,6-dimethyl-4- (2-methylthio-1-oxydo- 3-pyridyl) -1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester. 제1항에 있어서, 2-메톡시피리딘-3-카복스알데히드-1-옥사이드를 아세토아세트산 에틸 에스테르 및 암모니아와 반응시켜 2,6-디메틸-4-(1-옥시도-2-메톡시-3-피리딜)-1,4-디하이드로피리딘-3,5-디카복실산 디에틸에스테르를 수득함을 특징으로 하는 방법.The method of claim 1, wherein 2-methoxypyridine-3-carboxaldehyde-1-oxide is reacted with acetoacetic acid ethyl ester and ammonia to give 2,6-dimethyl-4- (1-oxido-2-methoxy- 3-pyridyl) -1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester. 제1항에 있어서, 2-메틸설피닐-3-카복스알데히드-1-옥사이드를 아세토아세트산 및 암모니아와 반응시켜 2,6-디메틸-4-(2-메틸설피닐-1-옥시도-3-피리딜)-1,4-디하이드로피리딘-3,5-디카복실산 디에틸에스테르를 수득함을 특징으로 하는 방법.The method of claim 1, wherein 2-methylsulfinyl-3-carboxaldehyde-1-oxide is reacted with acetoacetic acid and ammonia to give 2,6-dimethyl-4- (2-methylsulfinyl-1-oxydo-3 Pyridyl) -1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester. 제1항에 있어서, 피리딘-3-카복스알데히드-1-옥사이드를 3-아미노크로톤산 에틸 에스테르 및 4-클로로 아세토아세트산 에틸에스테르와 반응시켜 2-메틸-4-(1-옥시도-3-피리딜)-5-옥소-1,4,5,7-테트라하이드로푸로[3,4-b] 피리딘-3-카복실산 에틸에스테르를 수득함을 특징으로 하는 방법.The reaction mixture of claim 1, wherein the pyridine-3-carboxaldehyde-1-oxide is reacted with 3-aminocrotonic acid ethyl ester and 4-chloroacetoacetic acid ethyl ester. Pyridyl) -5-oxo-1,4,5,7-tetrahydrofuro [3,4-b] pyridine-3-carboxylic acid ethyl ester. 제1항에 있어서, 2-클로로피리딘-3-카복스알데히드-1-옥사이드를 3-아미노크로톤산 에틸 에스테르 및 4-클로로-아세토아세트산 에틸에스테르와 반응시켜 2-메틸-4-(1-옥시도-2-클로로-3-피리딜)-5-옥소-1,4,5,7-테트라하이드로푸로[3,4-b] 피리딘-3-카복실산 에틸에스테르를 수득함을 특징으로 하는 방법.The method of claim 1, wherein 2-chloropyridine-3-carboxaldehyde-1-oxide is reacted with 3-aminocrotonic acid ethyl ester and 4-chloro-acetoacetic acid ethyl ester to react with 2-methyl-4- (1-oxy Fig. 2-Chloro-3-pyridyl) -5-oxo-1,4,5,7-tetrahydrofuro [3,4-b] pyridine-3-carboxylic acid ethyl ester. 제1항에 있어서, 2-메틸피리딘-3-카복스알데히드-1-옥사이드를 3-아미노크로톤산 에틸 에스테르 및 4-클로로아세토아세트산 에틸에스테르와 반응시켜 4-(1-옥시도-2-메틸-3-피리딜)-5-옥소-1,4,5,7-테트라하이드로푸로[3,4-b] 피리딘-3-카복실산 에틸에스테르를 수득함을 특징으로 하는 방법.The method of claim 1, wherein 2-methylpyridine-3-carboxaldehyde-1-oxide is reacted with 3-aminocrotonic acid ethyl ester and 4-chloroacetoacetic acid ethyl ester to obtain 4- (1-oxido-2-methyl 3-pyridyl) -5-oxo-1,4,5,7-tetrahydrofuro [3,4-b] pyridine-3-carboxylic acid ethyl ester. 2-메틸티오피리딘-3-카복스알데히드-1-옥사이드, 3-아미노크로톤산 에틸 에스테르 및 4-클로로-아세토아세트산 에틸에스테르와 반응시켜 2-메틸-4-(1-옥시도-2-메틸티오-3-피리딜)-5-옥소-1,4,5,7-테트라하이드로푸로[3,4-b] 피리딘-3-카복실산 에틸 에스테르를 수득함을 특징으로 하는 방법.2-methylthiopyridine-3-carboxaldehyde-1-oxide, 3-aminocrotonic acid ethyl ester and 4-chloro-acetoacetic acid ethyl ester to react with 2-methyl-4- (1-oxido-2-methyl Thio-3-pyridyl) -5-oxo-1,4,5,7-tetrahydrofuro [3,4-b] pyridine-3-carboxylic acid ethyl ester. 제1항 내지 제5항 중 어느 하나의 항에 있어서, 염-형성기를 갖는, 일반식(Ⅰ)의 생성된 화합물을 약학적으로 허용되는 산부가염으로 전환시킴을 특징으로 하는 방법.The process according to any one of claims 1 to 5, characterized in that the resulting compound of formula (I) having a salt-forming group is converted into a pharmaceutically acceptable acid addition salt. ※참고사항:최초출원 내용에 의하여 공개하는 것임.※ Note: This is to be disclosed based on the first application.
KR1019820005887A 1981-12-30 1982-12-30 Method for producing N-oxide compound KR840002824A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH8359/81-9 1981-12-30
CH835981 1981-12-30

Publications (1)

Publication Number Publication Date
KR840002824A true KR840002824A (en) 1984-07-20

Family

ID=4339117

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019820005887A KR840002824A (en) 1981-12-30 1982-12-30 Method for producing N-oxide compound

Country Status (3)

Country Link
JP (1) JPS58126885A (en)
KR (1) KR840002824A (en)
ZA (1) ZA829573B (en)

Also Published As

Publication number Publication date
JPS58126885A (en) 1983-07-28
ZA829573B (en) 1983-10-26

Similar Documents

Publication Publication Date Title
IE42643L (en) 1, 4-dihydropyridinecarboxylic acid aralkyl esters.
GB1383625A (en) 1,4-dihydropyridine carboxylic acid compounds their production and their medicinal use
KR930017851A (en) Naphthalene Derivatives, Preparation Methods thereof, and Synthetic Intermediates thereof
IE37369B1 (en) Process for the manufacture of new 2-amino-1,4-dihydropyridines and their use as coronary agents
KR880006238A (en) Susceptibility enhancers against multidrug-resistant cancer cells and methods for preparing the same
KR840000534A (en) Method for producing dihydropyridine compounds
IE41251L (en) 1, 4-dihydropyridines
KR850005845A (en) Process for preparing 7-amino-3-substituted-methyl-3-cepem-4-carboxylic acid and lower alkylsilyl derivatives thereof
KR840004080A (en) Method for preparing salicylic acid derivative
KR840002824A (en) Method for producing N-oxide compound
KR860003244A (en) Oxazozolyl-1,4-dihydropyridine derivative and preparation method of acid addition thereof
KR890006620A (en) Quinoline derivatives and their preparation
CA1176255A (en) 1,4-dihydropyridine derivatives and processes for preparing the same
KR840006226A (en) Method for preparing tiatiazine derivatives
KR840001154A (en) Method for preparing 1,2-dithiol-3-ylidene ammonium derivative
JPS56140989A (en) 1,4-dihydrophyridine-3,5-dicarboxylic ester derivative or its salt
US4140691A (en) Process for preparing 3-[2-(4-benzamidopiperid-1-yl)ethyl]indole
DE68924010D1 (en) Process for the preparation of 1-alpha, 3-beta, 24-trihydroxy-delta-5 steroid derivatives.
EP0183091A3 (en) 1,4-dihydropyridines, process for their preparation and their use
KR890012968A (en) Preparation of Substituted Nicotinic Acid Ester
KR830006293A (en) Process for preparing a novel polyaza heterocyclic compound
KR850006177A (en) Method for preparing cinnamic acid derivatives
ES8706118A1 (en) 1,4-dihydropyridine derivative and production thereof
KR860004040A (en) Method for preparing 3,4-diazole derivative
KR900003178A (en) Process for preparing cefem compound